Thaliporphine protects ischemic and ischemic-reperfused rat hearts via an NO-dependent mechanism
- 1 March 2001
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 52 (3) , 446-453
- https://doi.org/10.1002/ddr.1146
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.Journal of Clinical Investigation, 1995
- EFFECT OF INCREASED MYOCARDIAL CYCLIC GMP INDUCED BY CYCLIC GMP‐PHOSPHODIESTERASE INHIBITION ON OXYGEN CONSUMPTION AND SUPPLY OF RABBIT HEARTSClinical and Experimental Pharmacology and Physiology, 1994
- Thaliporphine, a positive inotropic agent with a negative chronotropic actionEuropean Journal of Pharmacology, 1994
- Effects of SOD, catalase, and a novel antiarrhythmic drug, EGB 761, on reperfusion-induced arrhythmias in isolated rat heartsFree Radical Biology & Medicine, 1993
- Ischaemic injury mediatorNature, 1990
- The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusionCardiovascular Research, 1988
- ENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUMPublished by Elsevier ,1987
- Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro.Journal of Clinical Investigation, 1987
- Coronary Vascular Reactivity After Acute Myocardial IschemiaScience, 1982
- THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUMJournal of Clinical Investigation, 1955